Expression of transcription factors snail, slug, and twist in human bladder carcinoma.
BACKGROUND
Slug, snail, and twist are transcription factors that regulate the expression of tumor suppressors such as E-cadherin. In this study, we aimed to examine the expression of these transcription factors in human bladder carcinoma.


METHODS
We first investigated expression of slug, snail, twist and E-cadherin in five bladder Carcinoma cell lines by reverse transcription-polymerase chain reaction and western blotting. Furthermore, we investigated slug, snail, and twist and E-cadherin expression by immunohistochemistry with bladder carcinoma (tumor, n = 120; background, n = 42).


RESULTS
Expression of slug mRNA and protein was detected in all cell lines, twist was clearly expressed in two out of five bladder carcinoma cell lines, snail was not expressed, and E-cadherin was detected in 3 cell lines. 44.2% (53/120) of human bladder carcinoma tissues and 38% (16/42) background tissue showed an expression of twist; 62.5% (75/120) of human bladder carcinoma tissues and 40% (17/42) background tissue showed an expression of slug, 15.8% (19/120) of human bladder carcinoma tissues and 76% (32/42) background tissue showed an expression of snail, and 25.8% (31/120) cases were negative for E-cadherin expression in carcinoma tissues. Expression of slug and twist shows increased levels in tumors, whereas snail seems reduced. Statistically significant correlations were found between twist, slug, and E-cadherin expression. Immunohistochemistry analysis showed that twist was elevated with increasing tumor stage (P = 0.001), the grade (P < 0.001), the progression (P = 0.035). Slug was elevated and snail was reduced with increasing nodal involvement (tumor-node-metastasis status) (P = 0.004, P = 0.01). E-cadherin was reduced in expression corresponding with tumor grade (P < 0.01). Positive twist, slug and E-cadherin expression clearly predicted poorer PFS (P = 0.042, P = 0.014, P = 0.001). In the multivariate analysis, only snail and E-cadherin expression were independent prognostic factors for OS (P = 0.002, P < 0.001).


CONCLUSIONS
These data demonstrate that twist, snail and slug have inappropriate expression in bladder carcinoma and that this may play a part in the progression of human bladder carcinoma.
Yu
Qinchao
Q
Department of Urology Surgery, the Affiliated Hospital of Medical College, QingDao University, QingDao, Shan Dong Province, 266403, China.
Zhang
Kejun
K
Wang
Xinsheng
X
Liu
Xiangping
X
Zhang
Zemi
Z
D000368:Aged; D015703:Antigens, CD; D015153:Blotting, Western; D015820:Cadherins / Q000378:metabolism; D002277:Carcinoma / Q000235:genetics / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D045744:Cell Line, Tumor; D016009:Chi-Square Distribution; D002681:China; D018572:Disease-Free Survival; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008297:Male; D009367:Neoplasm Staging; D009687:Nuclear Proteins / Q000235:genetics / Q000378:metabolism*; D011379:Prognosis; D016016:Proportional Hazards Models; D012333:RNA, Messenger / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018570:Risk Assessment; D012307:Risk Factors; D000071250:Snail Family Transcription Factors; D013997:Time Factors; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism*; D051879:Twist-Related Protein 1 / Q000235:genetics / Q000378:metabolism*; D001749:Urinary Bladder Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000401:mortality / Q000473:pathology
D015703:Antigens, CD; C513384:CDH1 protein, human; D015820:Cadherins; D009687:Nuclear Proteins; D012333:RNA, Messenger; C000604407:SNAI1 protein, human; D000071250:Snail Family Transcription Factors; C103173:TWIST1 protein, human; D014157:Transcription Factors; D051879:Twist-Related Protein 1
Cancer Res. 2007 Oct 1;67(19):9207-13
17909026
J Biomed Sci. 2008 May;15(3):343-55
18183498
Ann Surg Oncol. 2005 Jun;12(6):488-96
15864483
J Cell Biochem. 2009 Oct 15;108(3):726-36
19681038
Lung Cancer. 2006 Dec;54(3):309-17
16996643
World J Gastroenterol. 2008 Feb 21;14(7):1044-52
18286686
Eur J Cancer. 2000 Feb;36(3):357-62
10708937
Br J Cancer. 2006 Jun 19;94(12):1816-22
16773075
Clin Cancer Res. 2003 Jul;9(7):2657-64
12855644
Gynecol Oncol. 2005 Apr;97(1):155-65
15790452
Cell Oncol. 2007;29(4):279-87
17641412
J Biol Chem. 2008 Aug 29;283(35):23514-23
18593711
Urol Oncol. 2009 May-Jun;27(3):268-76
18440840
Hepatology. 2009 Nov;50(5):1464-74
19821482
Am J Pathol. 1991 Jul;139(1):17-23
1713020
Anat Rec (Hoboken). 2009 Feb;292(2):262-70
19051271
Cancer Res. 2006 Apr 1;66(7):3365-9
16585154
J Exp Clin Cancer Res. 2009 Dec 21;28:158
20025748
Nat Rev Mol Cell Biol. 2002 Mar;3(3):155-66
11994736
Int J Cancer. 2010 May 1;126(9):2102-11
19795442
Cancer Lett. 2004 Jan 20;203(2):155-61
14732223
Hum Pathol. 2007 Apr;38(4):598-606
17258791
Cancer Res. 2007 Mar 1;67(5):1979-87
17332325
Cancer Res. 2007 Dec 1;67(23):11254-62
18056451
Curr Opin Cell Biol. 2003 Dec;15(6):740-6
14644200
Cancer Res. 2007 Dec 15;67(24):11721-31
18089802
Anticancer Res. 2008 Mar-Apr;28(2A):621-8
18507000
Diagn Mol Pathol. 2007 Dec;16(4):222-8
18043286
Pancreas. 2004 Oct;29(3):e77-83
15367897
Development. 2005 Jul;132(14):3151-61
15983400
Nat Rev Cancer. 2002 Jun;2(6):442-54
12189386
Curr Biol. 2004 Sep 7;14(17):R719-21
15341765
Semin Urol Oncol. 2000 Nov;18(4):313-22
11101096
Int J Dev Biol. 2004;48(5-6):365-75
15349812
Urol Oncol. 2010 Nov-Dec;28(6):591-6
19162513
J Exp Clin Cancer Res. 2010 Jul 01;29:88
20594328
Cell. 2004 Jun 25;117(7):927-39
15210113
Clin Cancer Res. 2007 Aug 15;13(16):4769-76
17699854
Cancer Res. 2002 Mar 15;62(6):1613-8
11912130
Am J Pathol. 2002 Nov;161(5):1881-91
12414534
J Cell Sci. 2003 Feb 1;116(Pt 3):499-511
12508111